Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Healthequity Inc shares valued at $720,433 were purchased by Stephen Neeleman on Apr 08 ’25. At $79.88 per share, Stephen Neeleman acquired 9,019 shares.
Also, Delano Ladd purchased 6,991 shares, netting a total of over 558,437 in proceeds.
Before that, Jon Kessler had added 101,545 shares to its account. In a trade valued at $8,111,359, the Director bought Healthequity Inc shares for $79.88 each.
As published in a research note from Raymond James on March 25, 2025, Healthequity Inc [HQY] has been rated up from an Outperform to a Strong buy and the price target has been revised to $115 from $120. Analysts at Mizuho started covering the stock with ‘”an Outperform”‘ outlook in a report released in early December. As of November 15, 2024, Goldman has initiated its “Neutral” rating for HQY. Earlier on April 04, 2024, JMP Securities initiated its rating. Their recommendation was “a Mkt outperform” for HQY stock.
Analyzing HQY Stock Performance
During the last five days, there has been a drop of approximately -3.65%. Over the course of the year, Healthequity Inc shares have dropped approximately -16.69%. Shares of the company reached a 52-week high of $115.59 on 02/13/25 and a 52-week low of $74.07 on 04/07/25. A 50-day SMA is recorded $99.40, while a 200-day SMA reached $90.25.
Support And Resistance Levels for Healthequity Inc (HQY)
According to the 24-hour chart, there is a support level at 78.04, which, if violated, would cause prices to drop to 76.14. In the upper region, resistance lies at 81.88. The next price resistance is at 83.82. RSI (Relative Strength Index) is 37.23 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -5.17, which suggests the price will decrease in the coming days. Percent R is at 70.01%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
